Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Clinical trial NCT01560416 · COMPLETED
Trial details
- NCT number
- NCT01560416
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-06-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.